Medium-chain acyl-coenzyme A dehydrogenase deficiency

Search Trials
Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies
Status:
Completed
Last Changed:
Dec 8, 2021
First Changed:
Aug 12, 2014
Disease(s):
Carnitine Palmitoyltransferase (CPT I or CPT II) Deficiency
Intervention(s):
UX007
Systemic Biomarkers of Brain Injury From Hyperammonemia
Status:
Recruiting
Last Changed:
Nov 1, 2021
First Changed:
Oct 26, 2020
Disease(s):
Urea Cycle Disorder
Use of Ravicti™ in Patients With MCAD Deficiency With the 985A>G (K304E) Mutation
Status:
Completed
Last Changed:
Sep 25, 2017
First Changed:
Jun 20, 2013
Disease(s):
Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency
Intervention(s):
Ravicti
A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)
Status:
Completed
Last Changed:
Feb 11, 2021
First Changed:
Jun 25, 2013
Disease(s):
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Intervention(s):
UX007
Brain Biomarkers Study
Status:
Recruiting
Last Changed:
Oct 26, 2020
First Changed:
Oct 26, 2020
Disease(s):
Urea Cycle Disorder

Connect. Empower. Inspire.